These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8442432)

  • 81. Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP).
    Açil Y; Brinckmann J; Notbohm H; Müller PK; Bätge B
    Scand J Clin Lab Invest; 1996 May; 56(3):275-83. PubMed ID: 8761532
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Use of stable isotopic tracers in studies of whole body calcium metabolism.
    Yergey AL; Vieira NE; Abrams SA; Marini J; Goans RE
    Connect Tissue Res; 1995; 31(4):291-3. PubMed ID: 15612371
    [TBL] [Abstract][Full Text] [Related]  

  • 83. An electron probe X-ray microanalytical study of bone mineral in osteogenesis imperfecta.
    Cassella JP; Garrington N; Stamp TC; Ali SY
    Calcif Tissue Int; 1995 Feb; 56(2):118-22. PubMed ID: 7736319
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The role of collagen in the declining mechanical properties of aging human cortical bone.
    Zioupos P; Currey JD; Hamer AJ
    J Biomed Mater Res; 1999 May; 45(2):108-16. PubMed ID: 10397964
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Abnormal Bone Collagen Cross-Linking in Osteogenesis Imperfecta/Bruck Syndrome Caused by Compound Heterozygous
    Gistelinck C; Weis M; Rai J; Schwarze U; Niyazov D; Song KM; Byers PH; Eyre DR
    JBMR Plus; 2021 Mar; 5(3):e10454. PubMed ID: 33778323
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Abnormal amino acid analyses obtained from osteogenesis imperfecta dentin.
    Gage JP; Francis MJ; Smith R
    J Dent Res; 1988 Aug; 67(8):1097-102. PubMed ID: 3165403
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Osteonectin, bone proteoglycan, and phosphophoryn defects in a form of bovine osteogenesis imperfecta.
    Termine JD; Robey PG; Fisher LW; Shimokawa H; Drum MA; Conn KM; Hawkins GR; Cruz JB; Thompson KG
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2213-7. PubMed ID: 6585794
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Abnormal collagen and mineral formation in osteogenesis imperfecta.
    Cassella JP; Ali SY
    Bone Miner; 1992 May; 17(2):123-8. PubMed ID: 1611296
    [No Abstract]   [Full Text] [Related]  

  • 89. Reduced concentrations of collagen cross-links are associated with reduced strength of bone.
    Oxlund H; Barckman M; Ortoft G; Andreassen TT
    Bone; 1995 Oct; 17(4 Suppl):365S-371S. PubMed ID: 8579939
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Purification of collagen crosslinks; potential biomarkers for bone disorders.
    McGuinness BJ; Casserly UM; Power MJ; Fottrell PF
    Biochem Soc Trans; 1995 May; 23(2):386S. PubMed ID: 7672419
    [No Abstract]   [Full Text] [Related]  

  • 91. X-ray pole figure analysis of apatite crystals and collagen molecules in bone.
    Sasaki N; Sudoh Y
    Calcif Tissue Int; 1997 Apr; 60(4):361-7. PubMed ID: 9075634
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Dentine is biochemically abnormal in osteogenesis imperfecta.
    Gage JP; Francis MJ; Whitaker GE; Smith R
    Clin Sci (Lond); 1986 Apr; 70(4):339-46. PubMed ID: 3084156
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Collagen cross-link profiles and mineral are different between the mandible and femur with site specific response to perturbed collagen.
    Romanowicz GE; Terhune AH; Bielajew BJ; Sexton B; Lynch M; Mandair GS; McNerny EMB; Kohn DH
    Bone Rep; 2022 Dec; 17():101629. PubMed ID: 36325166
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Calcium kinetics in children with osteogenesis imperfecta type III and IV: pre- and post-growth hormone therapy.
    Vieira NE; Goans RE; Weiss GH; Hopkins E; Marini JC; Yergey AL
    Calcif Tissue Int; 2000 Aug; 67(2):97-100. PubMed ID: 10920211
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Osteogenesis imperfecta: an x ray fibre diffraction study.
    Bradshaw JP; Miller A
    Ann Rheum Dis; 1986 Sep; 45(9):750-6. PubMed ID: 3767461
    [TBL] [Abstract][Full Text] [Related]  

  • 96. High-performance liquid chromatographic determination of 3-hydroxypyridinium derivatives as new markers of bone resorption.
    Kamel S; Brazier M; Desmet G; Picard C; Mennecier I; Sebert J
    J Chromatogr; 1992 Feb; 574(2):255-60. PubMed ID: 1618957
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Collagen crosslinks in fibromyalgia.
    Sprott H; Müller A; Heine H
    Arthritis Rheum; 1997 Aug; 40(8):1450-4. PubMed ID: 9259425
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Rapid method for the isolation of hydroxylysylpyridinoline and lysylpyridinoline from concentrated bone hydrolysates by liquid chromatographic techniques.
    Lamprecht G
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 691(2):297-304. PubMed ID: 9174265
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Factors regulating bone maturity and strength in poultry.
    Rath NC; Huff GR; Huff WE; Balog JM
    Poult Sci; 2000 Jul; 79(7):1024-32. PubMed ID: 10901206
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Altered x-ray diffraction pattern is accompanied by a change in the mode of cross-link formation in lipodermatosclerosis.
    Brinckmann J; Açil Y; Tronnier M; Notbohm H; Bätge B; Schmeller W; Koch MH; Müller PK; Wolff HH
    J Invest Dermatol; 1996 Oct; 107(4):589-92. PubMed ID: 8823365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.